Navigation Links
EMD Serono to Adopt Revised and Strengthened PhRMA Code
Date:7/10/2008

- Revised Code Demonstrates Strong Commitment to Ethical Information

Exchange between Physician Community and Leading Biotechnology and

Pharmaceutical Companies -

ROCKLAND, Mass., July 10 /PRNewswire/ -- EMD Serono, Inc. announced today that the company has adopted and will fully implement, the revised and strengthened PhRMA Code on Interactions with Healthcare Professionals. The revised voluntary Code, which builds on the prior 2002 version, was approved unanimously by the PhRMA Board of Directors and announced by PhRMA earlier today. The revised Code reaffirms that interactions between company representatives and healthcare professionals should be focused on informing healthcare professionals about the benefits and risks of medicines to help enhance patient care, providing scientific and educational information, and supporting medical research and takes effect in January 2009. The revised Code reinforces the commitment of America's leading pharmaceutical research and biotechnology companies, including EMD Serono, to provide up-to-date, accurate information to healthcare providers about life-saving and life-enhancing medicines.

The adoption of the revised Code reaffirms EMD Serono's pledge to focus interactions between company representatives and healthcare professionals on informing them of our products and advancing tomorrow's medicines. EMD Serono adopted the prior version of the Code in 2002 and actively worked with PhRMA on enhancements to the Code. EMD Serono fully supports the underlying purpose of the enhanced Code to ensure that interactions between industry and healthcare professionals meet the highest ethical standards and benefit patients. EMD Serono has implemented a comprehensive company-wide Compliance Program; introduction of the revised PhRMA code aligns with the company's commitment to best practices and ethics in serving the medical community and patients.

"EMD Serono was an early cont
'/>"/>

SOURCE EMD Serono, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ZymoGenetics and Merck Serono Receive FDA Special Protocol Assessment for Atacicept Pivotal Study in Lupus Nephritis
2. Video and Photo: EMD Serono Launches easypod(R), New Electronic Growth Hormone Injection Device
3. EMD Serono Announces Planned Investment of $50 Million in Research Center in Massachusetts
4. Thermo Fisher Scientific Executive Officers Adopting SEC Rule 10b5-1 Trading Programs
5. BioLife Solutions CryoStor(TM) Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New, Non-Embryonic Source of Stem Cells
6. Coley Pharmaceutical Group Adopts Shareholder Rights Plan
7. Oncologists Want to See Significant Improvement in Overall Survival Before Adopting Targeted Polytherapy in a First-Line Setting
8. Monsanto Company Executives Adopt 10b5-1 Trading Plans
9. YM Biosciences announces adoption of renewed Shareholders Rights Plan
10. Hospitals Adopt STERIS Advanced Room Sterilization Technology in the Fight Against Superbugs
11. Novo Nordisk Applauds Adoption of World Diabetes Day Resolutions by U.S. Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... CA (PRWEB) July 23, 2014 ... cell therapy in the US aimed at improving the ... their newest clinical study for Parkinson’s disease. StemGenex ... of stem cell therapy are paramount when providing care ... clinical study makes stem cell therapy accessible to the ...
(Date:7/23/2014)... Iowa (PRWEB) July 23, 2014 DuPont ... the business as vice president of Agricultural Biotechnology (ABT), ... Biotechnology where he served most recently as president, chief ... biotechnology and business leadership in the seed and crop ... said Paul E. Schickler , president of DuPont ...
(Date:7/23/2014)... , July 23, 2014 regulated information ... research and development pipeline with positive topline results ... brivaracetam . This study was designed to evaluate the ... and 200 mg/day, without titration) compared to placebo, ... with partial-onset seizures, not fully controlled despite treatment ...
(Date:7/23/2014)... VEGAS , July 23, 2014  GrowBLOX Sciences, Inc. ... today that it is filing for two medical marijuana dispensary ... locations are in addition to the Clark County, ... a special use permit, as previously announced.  GrowBLOX ... to be submitting two new applications for dispensaries in the ...
Breaking Biology Technology:StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 3DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 2DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7GrowBLOX Sciences, Inc. Files for Two Additional Medical Marijuana Dispensaries in Las Vegas 2GrowBLOX Sciences, Inc. Files for Two Additional Medical Marijuana Dispensaries in Las Vegas 3
... 11 Signalife,Inc. (Amex: SGN ) announced ... its previously-announced merger or similar business combination with,Heart ... has been,appointed to proceed with due diligence and ... presently contemplated, a new parent,company will be established ...
... Ltd. launches a multicenter study using the CiTop™ technology in ... device company, has announced today successful experiences using CiTop™ ExPander™ ... , ... Rehovot , Israel (PRWEB) ...
... (T-ALL) , The white blood cells in our ... However, in leukemia, the formation of white blood cells ... blood cells multiply out of control without fully maturing. ... making patients more susceptible to infections. T-ALL, a particular ...
Cached Biology Technology:Signalife Board Approves Merger 2Signalife Board Approves Merger 3Ovalum Ltd. Announces Success in Coronary Cases Using CiTop™ ExPander™ Guidewire 2Not the protein, but its location in the cell, determines the onset of leukemia 2
(Date:7/23/2014)... and forming knots. Scientists study these knots to understand ... useful for gene sequencing techniques). Cristian Micheletti, professor at ... and his team have been carrying out research in ... their latest paper, just published in the journal ... first author and PhD student at SISSA, and colleagues ...
(Date:7/23/2014)... release is available in German . ... sensory modalities for orientation, some of which might be ... take the polarization pattern produced by sunlight in the ... the Max Planck Institute for Ornithology in Seewiesen, Germany, ... Israel that a night active mammal, the greater mouse-eared ...
(Date:7/23/2014)... for Alzheimer,s disease, the devastating neurological disease affecting ... now reporting new progress on a set of ... promise as a potential oral therapy for Alzheimer,s. ... Medicinal Chemistry . , Carlo Ballatore, Kurt R. ... brain, the protein known as tau binds to ...
Breaking Biology News(10 mins):Bats use the evening sky's polarization pattern for orientation 2
... flu spread from Mexico to Texas and then fanned out ... behavior. Families kept children home from school, postponed trips to ... so doing, the American population may have inadvertently altered the ... the spread of emerging infectious diseases, and how the spread ...
... 4 April 2009 | An international symposium ... the use of nuclear technologies to enhance animal nutrition and ... can be transmitted to humans, such as swine and avian ... over 100 countries will present up-to-date findings for solving or ...
... a relatively widespread phenomenon, the experts have still not been ... of workplace abuse or bullying. Basing their work on previous ... Madrid and Jos Lus Graa, of the Faculty of Psychology ... as a "process of systematic and repeated aggression by a ...
Cached Biology News:Scientists examine perceptions of risk and the spread of disease 2FAO/IAEA Symposium to address animal production and health 2Bullies have harassed 14 percent of workers over past 6 months 2
Homo sapiens inhibin, beta B (activin AB beta polypeptide) Antigen: Recombinant Protein(142~254aa)...
Self Closing Forceps...
Mouse IL-31 RA Biotinylated Affinity Purified PAb...
... 1 outflow Single-cell and patch delivery ... solution change Very small dead volume , ... 360, 250 and 100 micron delivery tips ... micromanipulator Available in 4, 8, and 16 ...
Biology Products: